Scinai Immunotherapeutics Ltd.
SCNI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $4,796 | -$6,500 | -$5,796 | -$8,206 |
| Dep. & Amort. | $1,649 | $514 | $562 | $471 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $682 | $1,139 | $1,602 | $2,757 |
| Change in WC | $112 | -$646 | $446 | $701 |
| Other Non-Cash | -$13,574 | -$3,889 | -$4,079 | -$3,149 |
| Operating Cash Flow | -$6,335 | -$9,382 | -$7,265 | -$7,426 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$12 | -$637 | -$836 | -$139 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$12 | -$637 | -$836 | -$139 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | -$393 |
| Stock Issued | $2,000 | $139 | $6,749 | $21,430 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1,441 | $947 | $27 | $393 |
| Financing Cash Flow | $3,441 | $1,086 | $6,776 | $21,430 |
| Forex Effect | -$9 | -$272 | -$1,977 | $575 |
| Net Chg. in Cash | -$2,915 | -$9,205 | -$3,302 | $14,440 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $5,010 | $14,215 | $17,517 | $2,931 |
| End Cash | $2,095 | $5,010 | $14,215 | $17,517 |
| Free Cash Flow | -$6,347 | -$10,019 | -$8,101 | -$7,565 |